Clinical Trial: A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Dry Eye Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 3b Study to Investigate the Effect of 0.003% AR-15512 on the Ocular Surface Characteristics of Subjects With Dry Eye Disease
Brief Summary:
The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).
Read more